{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:17:46Z","timestamp":1787872666721,"version":"build-2784847793"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejso.2026.112031","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:23:47Z","timestamp":1784615027000},"page":"112031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rethinking stage IVB gallbladder cancer: Decoupling N2M0 from M1 via de-escalation, chemotherapy, and risk stratification"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1074-1513","authenticated-orcid":false,"given":"Yuxuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4982-3692","authenticated-orcid":false,"given":"Kaiju","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangsong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2026.112031_bib1","series-title":"StatPearls","article-title":"Anatomy, lymphatic system","author":"Null","year":"2026"},{"issue":"1","key":"10.1016\/j.ejso.2026.112031_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer","volume":"8","author":"Roa","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.ejso.2026.112031_bib3","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.ejso.2026.112031_bib5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00000658-199211000-00007","article-title":"Radical surgery for gallbladder carcinoma. Long-term results","volume":"216","author":"Shirai","year":"1992","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2026.112031_bib6","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1186\/s12885-020-07578-7","article-title":"Modification of the 8th American joint committee on cancer staging system for gallbladder carcinoma to improve prognostic precision","volume":"20","author":"Jiang","year":"2020","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2026.112031_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/bjsopen\/zraf056","article-title":"Assessment of nodal staging and risk factors for nodal involvement in gallbladder cancer","volume":"9","author":"Balakrishnan","year":"2025","journal-title":"BJS Open"},{"issue":"4","key":"10.1016\/j.ejso.2026.112031_bib8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/SLA.0000000000002385","article-title":"Surgical management of gallbladder cancer: simple versus extended cholecystectomy and the role of adjuvant therapy","volume":"266","author":"Kasumova","year":"2017","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.ejso.2026.112031_bib9","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.hpb.2024.09.004","article-title":"The impact of lymph node ratio on survival in gallbladder cancer: a national cancer database analysis","volume":"26","author":"Khomiak","year":"2024","journal-title":"HPB"},{"issue":"2","key":"10.1016\/j.ejso.2026.112031_bib10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1245\/s10434-020-08858-z","article-title":"Extended resections for advanced gallbladder cancer: results from a nationwide cohort study","volume":"28","author":"Kuipers","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2026.112031_bib11","series-title":"Surveillance, Epidemiology, and End Results (SEER) program","year":"2025"},{"issue":"3","key":"10.1016\/j.ejso.2026.112031_bib12","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3390\/cancers13030547","article-title":"Validation of the 8th edition American Joint Commission on Cancer (AJCC) gallbladder cancer staging system: prognostic discrimination and identification of key predictive factors","volume":"13","author":"Giannis","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ejso.2026.112031_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/COC.0b013e318287bb48","article-title":"Surgical treatment of advanced gallbladder cancer","volume":"38","author":"Niu","year":"2015","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.112031_bib14","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.sla.0000154118.07704.ef","article-title":"An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center","volume":"241","author":"Dixon","year":"2005","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejso.2026.112031_bib15","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"18","key":"10.1016\/j.ejso.2026.112031_bib16","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1200\/JCO.21.02568","article-title":"Long-term outcomes and exploratory analyses of the randomized phase III BILCAP study","volume":"40","author":"Bridgewater","year":"2022","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejso.2026.112031_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-026-01130-5","article-title":"Perioperative approaches for patients with biliary tract cancer","author":"Zorigtbaatar","year":"2026","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2026.112031_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw202","article-title":"Adjuvant therapy for resected gallbladder cancer: analysis of the national cancer data base","volume":"109","author":"Mantripragada","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ejso.2026.112031_bib19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4174\/jkss.2013.84.3.168","article-title":"Impact of lymph node ratio as a valuable prognostic factor in gallbladder carcinoma, focusing on stage IIIB gallbladder carcinoma","volume":"84","author":"Choi","year":"2013","journal-title":"J Korean Surg Soc"},{"issue":"8","key":"10.1016\/j.ejso.2026.112031_bib20","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1245\/s10434-023-13533-0","article-title":"Major postoperative complications limit adjuvant therapy administration in patients undergoing pancreatoduodenectomy for distal cholangiocarcinoma or pancreatic ductal adenocarcinoma","volume":"30","author":"Macfie","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2026.112031_bib21","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1245\/s10434-020-08973-x","article-title":"Adjuvant chemotherapy in resectable gallbladder cancer is underutilized despite benefits in node-positive patients","volume":"28","author":"Kemp Bohan","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2026.112031_bib22","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3390\/cancers17121919","article-title":"Individualized prediction of postoperative survival in gallbladder cancer: a nomogram based on SEER data and external validation","volume":"17","author":"Liu","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2026.112031_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ejso.2026.112031_bib24","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3390\/cancers13051089","article-title":"Prognostic value of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) in gallbladder cancer; 65 IU\/mL of CA 19-9 is the new cut-off value for prognosis","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ejso.2026.112031_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/bjs.10415","article-title":"Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer","volume":"104","author":"Yamashita","year":"2017","journal-title":"Br J Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326006505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798326006505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:33:53Z","timestamp":1787870033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798326006505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0748798326006505"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112031","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking stage IVB gallbladder cancer: Decoupling N2M0 from M1 via de-escalation, chemotherapy, and risk stratification","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2026.112031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112031"}}